Liverpool ChiroChem Revenue and Competitors

Location

N/A

Total Funding

Chemicals

Industry

Estimated Revenue & Valuation

  • Liverpool ChiroChem's estimated annual revenue is currently $3.5M per year.(i)
  • Liverpool ChiroChem's estimated revenue per employee is $106,061

Employee Data

  • Liverpool ChiroChem has 33 Employees.(i)
  • Liverpool ChiroChem grew their employee count by 22% last year.

Liverpool ChiroChem's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Operations ManagerReveal Email/Phone
3
Research ChemistReveal Email/Phone
4
Research ChemistReveal Email/Phone
5
Research ChemistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A356%N/AN/A
#2
$7.5M21-38%N/AN/A
#3
$3.5M516%N/AN/A
#4
N/A1187%N/AN/A
#5
$1.7M356%N/AN/A
#6
N/A29-3%N/AN/A
#7
N/A62-3%N/AN/A
#8
$1.7M605%N/AN/A
#9
$15M150-6%N/AN/A
#10
N/A10%N/AN/A
Add Company

What Is Liverpool ChiroChem?

Liverpool ChiroChem supplies specialist building blocks for pharmaceutical research and biotechnology. LCC was established in Liverpool, United Kingdom, in June 2014. The founding team consists of chemists with academic and industrial experience that have developed state-of-the-art synthetic methods in asymmetric catalysis. LCC's methods give access to a wide range of chiral amines in excellent enantiomeric purity. Our initial focus is on the production and supply of chiral piperidines, which are of great importance to drug discovery and development due to their excellent pharmacokinetic properties e.g. improved solubility and bioavailability. Our own unique production methods combined with our strong relationships with specialist manufacturers allow us to guarantee: •Unique products. •Excellent chemical and enantiomeric purity. •Highly competitive pricing. •Catalogue compounds held in stock, ready for next day delivery to UK. We base ourselves around 3 resolute facts : •The pharmaceutical industry requires a continual feedstock of new drug molecules. •Medicinal chemists require a continual supply of new building blocks in order to produce new drugs. •LCC's catalytic methods allow commercial production and supply of specialist building blocks that have long been highly desired but largely unavailable using traditional methods, which lack the efficiency to be commercially viable. Please visit us at http://www.liverpoolchirochem.com/ Or contact us at sales@liverpoolchirochem.com

keywords:N/A

N/A

Total Funding

33

Number of Employees

$3.5M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Liverpool ChiroChem News

2022-04-17 - Deepbridge Capital reports second successive year of record ...

... novel chemical technology developer Liverpool ChiroChem and sustainable algae manufacturing tech company AlgaeCytes. Like this article?

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A336%N/A
#2
$8.8M34-3%N/A
#3
$4.4M3455%N/A
#4
$5.7M34-3%N/A
#5
$5.9M35-3%N/A